Cargando…
Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention
With a global estimate of 2.5 million new infections of HIV occurring yearly, discovering novel methods to help stem the spread of the virus is critical. The use of antiretroviral chemoprophylaxis for preventing HIV after accidental or occupational exposure and in maternal to fetal transmission has...
Autores principales: | Clauson, Kevin A., Polen, Hyla H., Joseph, Shine A., Zapantis, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139751/ https://www.ncbi.nlm.nih.gov/pubmed/25147587 |
Ejemplares similares
-
1293. The Next Step in PrEP: Evaluating Outcomes of a Pharmacist-Run HIV Pre-Exposure Prophylaxis (PrEP) Clinic
por: Ryan, Keenan, et al.
Publicado: (2018) -
Ability of online drug databases to assist in clinical decision-making with infectious disease therapies
por: Polen, Hyla H, et al.
Publicado: (2008) -
The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020) -
Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV
por: Broekhuis, Jordan M., et al.
Publicado: (2018) -
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
por: Nozza, Silvia, et al.
Publicado: (2022)